Gastric cancer: Tumor markers as predictive factors for preoperative staging

Journal of Gastrointestinal Cancer

Volumn 42, Issue 3, 2011, Pages 127-130

  Cidón, Esther Uña ^a   Bustamante, Rosa ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Gastric cancer; Preoperative staging; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; EARLY CANCER; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 80054973826     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9161-0     Document Type: Article

References (31)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47. (Pubitemid 34110469)
2. Ries LA, Kosary CL, Hankey BF. SEER cancer statistics review 1973-1995. Bethesda: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute; 1998.
3. Allum WH, Powell DJ, McConkey CC, Fielding JW. Gastric cancer: a 25-year review. Br J Surg. 1989;76:535-40. (Pubitemid 19155720)
4. Wanebo HJ, Kennedy BJ, Chmiel J, Steele Jr G, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg. 1993;218:583-92. (Pubitemid 23339110)
5. Akoh JA, Macintyre IM. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg. 1992;79:293-9.
6. Catalano V, Labianca R, Beretta GD, Gatta G, De Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2009;71:127-64.
7. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Masayoshi M, Ohkura H, et al. The usefulness of CEA and/or CA 19.9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142-5. (Pubitemid 37221564)
8. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, et al. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer. 1994;73:2703-8. (Pubitemid 24166254)
9. Tachibana M, Takemoto Y, Nakashima Y, Kinugasa S, Coto T, Dhar DK, et al. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer. J Am Coll Surg. 1998;187:64-8. (Pubitemid 28303534)
10. Sakamoto J, Nakazato H, Teramukai S, Ohashi Y, Takahashi Y, Mai M, et al. Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan. Surg Oncol. 1996;5:133-9. (Pubitemid 26385514)
11. Maehara Y, Kusumoto T, Takahashi I, Kakeji Y, Baba H, Akazawa K, et al. Predictive value of preoperative carcinoembryonic antigen levels for the prognosis of patients with welldifferentiated gastric cancer. A multivariate analysis. Oncology. 1994;51:234-7. (Pubitemid 24113204)
12. Rakic S, Jagodic M, Adanja-Grujic G. Levels of tumor markers and erythrocyte sedimentation rate in intestinal and diffuse gastric cancer. Arch Gastroenterol. 1997;16(1):5-6. (Pubitemid 26414417)
13. Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J. Clinical significance and prognostic value of CA 72.4 compared with CEA and CA 19.9 in patients with gastric cancer. Dis Markers. 2000;16(3-4):105-10. (Pubitemid 32591564)
14. Gaspar MJ, Arribas I, Coca MC, Díez-Alonso M. Prognostic value of carcinoembryonic antigen, CA 19.9 and CA 72.4 in gastric carcinoma. Tumour Biol. 2001;22(5):318-22. (Pubitemid 32823950)
15. Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA 72.4, CEA, TPA, CA 19.9 and CA 125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology. 2002;49(46):1157-60.
16. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, et al. Prognostic significance of CEA, CA 19.9 and CA 72.4 preoperative serum levels in gastric carcinoma. Oncology. 1999;57(1):55-62. (Pubitemid 29308672)
17. Louhimo J, Kokkola A, Alfthan H, Stenman U, Haglund C. Preoperative hCGbeta and CA 72.4 are prognostic factors in gastric cancer. Int J Cancer. 2004;111:939-3.
18. Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O'Brien M, et al. The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer. Eur J Cancer. 1996;32A:63-8.
19. International Union Against Cancer. In: Sobin LH, Wittekind Ch, editors. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss Book; 2002.
20. Yano T, Nakatani K, Watanabe A, Sawada H, Okumura T, Yamada Y, et al. Utility of measurement of tumor markers for preoperative staging of gastric cancer. Nippon Geka Gakkai Zasshi. 1993;94(9):977-87.
21. Wobbes T, Thomas CMG, Segers MFG. Evaluation of seven tumour markers (CA 50, CA 19.9, CA 19.9 TruQuant, CA 72.4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma. Cancer. 1992;69:2036-41.
22. Guadagni F, Roselli M, Cosimelli M, Ferroni P, Spila A, Casaldi V, et al. Correlation between positive CA 72.4 serum levels and lymph node involvement in patients with gastric carcinoma. Anticancer Res. 1993;13(6B):2409-13. (Pubitemid 24103283)
23. Duraker N, Çelik AN. The prognostic significance of preoperative serum CA 19.9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol. 2001;76:266-71. (Pubitemid 32381683)
24. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, et al. Prognostic significance of CEA, CA 19.9 and CA 72.4 preoperative serum levels in gastric carcinoma. Oncology. 1999;57(1):55-62. (Pubitemid 29308672)
25. Rakic S, Jagodic M, Adanja-Grujic G. Levels of tumor markers and erythrocyte sedimentation rate in intestinal and diffuse gastric cancer. Arch Gastroenterol. 1997;16(1):5-6. (Pubitemid 26414417)
26. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. The prognostic value of preoperative serum levels of CEA and CA 19.9 in patients with gastric cancer. Am J Gastroenterol. 1996;91(1):49-53. (Pubitemid 26026036)
27. Goral V, Yesilbagdan H, Kaplan A, Sit D, Celik M. The role of CA 72.4, a new tumor marker in gastric cancer. Turk Klin Tip Bilim Derg. 2006;26(1):3-8. (Pubitemid 43266958)
28. Gaspar MJ, Arribas I, Coca MC, Díez-Alonso M. Prognostic value of carcinoembryonic antigen, CA 19.9 and CA 72.4 in gastric carcinoma. Tumour Biol. 2001;22(5):318-22. (Pubitemid 32823950)
29. Tachibana M, Takemoto Y, Nakashima Y. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer. J Am Coll Surg. 1998;187:64-8. (Pubitemid 28303534)
30. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, et al. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer. 1994;73(11):2703-8. (Pubitemid 24166254)
31. Louhimo J, Kokkola A, Alfthan H, Stenman U, Haglund C. Preoperative hCGbeta and CA 72.4 are prognostic factors in gastric cancer. Int J Cancer. 2004;111:939-3.